GlassScriptPhysician profile
Anthony P Nikko
NPI 1962649491
$8,521.66
in general payments reported to CMS, 2019-2025
37 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $895 · 2021: $1,209 · 2022: $1,612 · 2023: $1,653 · 2024: $1,311 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,019 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,018.75 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,288.84 | 2019-2025 | |
| Abbvie INC. | $1,174.95 | 2021-2025 | |
| Allergan, INC. | $769.15 | 2019-2022 | |
| Janssen Biotech, INC. | $716.35 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Galderma Laboratories, L.P. | $492.87 | 2019-2025 | Aklief, Oracea, Nemluvio |
| Almirall LLC | $491.04 | 2019-2023 | Klisyri |
| Lilly USA, LLC | $487.65 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Merz North America, INC. | $431.19 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $370.26 | 2019-2025 | Siliq, Jublia, Cabtreo |
| Dermavant Sciences, INC. | $240.82 | 2023-2024 | Vtama |
| Incyte Corporation | $237.21 | 2021-2025 | Opzelura |
| Vyne Pharmaceuticals INC. | $226.94 | 2020-2021 | |
| Leo Pharma INC. | $202.70 | 2019-2025 | Adbry, Anzupgo |
| Pfizer INC. | $166.16 | 2020-2023 | |
| Arcutis Biotherapeutics, INC. | $149.61 | 2023-2025 | Zoryve |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $143.43 | 2022-2025 | Sotyktu, Sprycel |
| Amgen INC. | $115.59 | 2022-2025 | Otezla, Otezla |
| Organon LLC | $99.26 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $89.06 | 2020-2025 | Ilumya |
| Genzyme Corporation | $82.24 | 2022-2025 | |
| Journey Medical Corporation | $71.81 | 2019-2022 | |
| Mission Pharmacal Company | $68.86 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $55.27 | 2022-2023 | Seglentis |
| Strata Skin Sciences, INC. | $54.81 | 2019-2023 | Xtrac |
| Regeneron Healthcare Solutions, INC. | $50.34 | 2021-2022 | |
| Ucb, INC. | $38.00 | 2025 | Bimzelx |
| Mayne Pharma Commercial LLC | $30.33 | 2023 | |
| Mentor Worldwide LLC | $23.37 | 2021 | |
| Verrica Pharmaceuticals INC. | $22.12 | 2023 | Ycanth |
| Promius Pharma LLC | $20.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.63 | 2021 | |
| Dermira, INC. | $17.71 | 2020 | |
| Kerecis Limited | $17.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Krystal Biotech INC | $15.43 | 2025 | Vyjuvek |
| Celgene Corporation | $14.20 | 2019 | |
| Fidia Pharma USA INC. | $14.20 | 2024 | |
| Medimetriks Pharmaceuticals, INC. | $13.94 | 2025 | Clindacin Etz, Neo-Synalar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Nikko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.